Predictors of disability extremes in patients with multiple sclerosis treated with interferon-beta using the Swedish multiple sclerosis registry

被引：0
|
作者：
Fink, K. [1 ]
Glaser, A. [1 ]
Fogdell-Hahn, A. [1 ]
Hillert, J. [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
来源：
JOURNAL OF NEUROLOGY | 2013年 / 260卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P955
引用
收藏
页码：S262 / S262
页数：1
相关论文
共 50 条
  • [1] Depression in interferon-beta treated multiple sclerosis patients
    Guedes, R.
    Peixoto de Sousa, C.
    Curral, R.
    Silveira, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S466 - S467
  • [2] Arthritis and bursitis in multiple sclerosis patients treated with interferon-beta
    Strueby, L
    Nair, B
    Kirk, A
    Taylor-Gjevre, RM
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2005, 34 (06) : 485 - 488
  • [3] The measurement of antibodies binding to interferon-beta in Iranian multiple sclerosis patients treated with interferon-beta
    Jangouk, P
    Hooshmand, E
    Vaezeafshar, R
    Lotfi, J
    Amirzargar, A
    Nikbin, B
    JOURNAL OF NEUROLOGY, 2004, 251 : 64 - 64
  • [4] Subunits and isoforms of Interferon receptor in multiple sclerosis patients treated with Interferon-beta
    Serana, F.
    Capra, R.
    Ghidini, C.
    Guidolin, L.
    Imberti, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 271 - 271
  • [5] Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta
    Batocchi, AP
    Rotondi, M
    Caggiula, M
    Frisullo, G
    Odoardi, F
    Nociti, V
    Carella, C
    Tonali, PA
    Mirabella, M
    JOURNAL OF NEUROIMMUNOLOGY, 2003, 139 (1-2) : 150 - 154
  • [6] Cellular immune responses in multiple sclerosis patients treated with interferon-beta
    Bustamante, M. F.
    Rio, J.
    Castro, Z.
    Sanchez, A.
    Montalban, X.
    Comabella, M.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2013, 171 (03): : 243 - 246
  • [7] Inflammatory musculoskeletal manifestations in multiple sclerosis patients treated with interferon-beta
    Strueby, L
    Nair, B
    Kirk, A
    Taylor-Gjevre, R
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (07) : 1405 - 1405
  • [8] Non-adherence to interferon-beta therapy in Swedish patients with multiple sclerosis
    Cunningham, A.
    Gottberg, K.
    von Koch, L.
    Hillert, J.
    ACTA NEUROLOGICA SCANDINAVICA, 2010, 121 (03): : 154 - 160
  • [9] Antibodies to commercially available interferon-beta molecules in multiple sclerosis patients treated with natural interferon-beta
    Mayorga, C
    Luque, G
    Romero, F
    Guerrero, R
    Blanca, M
    Fernandez, O
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1999, 118 (2-4) : 368 - 371
  • [10] Interferon-beta neutralising antibodies in Canadian multiple sclerosis patients treated with different interferon-beta products
    Grossberg, S. E.
    Gehshan, A.
    Long, C.
    Chuppa, S. L.
    Nicholson, K.
    Grossberg, L. D.
    MULTIPLE SCLEROSIS, 2006, 12 : S207 - S208
12345